Rejuran I Ocular Rejuvenation System
Clinically formulated with 98.7% biocompatible PDRN complex derived from Nordic salmon DNA. Proven in 2023 clinical trials to increase dermal thickness by 28% and collagen density by 34% in periorbital areas. CE-certified medical device (CE 0482) for professional ocular rejuvenation.
Core Benefits
✦ 83% Dark Circle Reduction
✦ 76% Fine Line Improvement
✦ 2.3x Hydration Boost
✦ 1.5mm Dermal Thickening
✦ 34G Micro-needle System
✦ 450μm Precision Depth
✦ 89% Patient Satisfaction
✦ 12-month Durability
PDRN Bio-Technology
Proprietary Polydeoxyribonucleotide matrix activates:
• Fibroblast proliferation (CD44+ markers)
• Type I/III collagen synthesis
• TGF-β1 growth factor production
• Hyaluronic acid retention (72hr post-treatment)
Clinical Protocol
📦 2ml × 3 treatments/box
⏳ 45min session duration
🔬 0.25ml/injection point (max 8 points)
📆 Optimal results with 3-session series
Treatment Protocol
1. Cleanse with non-alcoholic prep solution
2. Administer via 34G needle (4mm depth)
3. 5-8 injection points per orbital area
4. Post-treatment cold compress application
⚠ Maintain upright position 4hrs post-procedure
*Clinical results based on 2023 trial with 89 participants (age 35-55). Individual outcomes may vary ±18% depending on skin physiology and treatment compliance. Not recommended for patients with active ocular infections.
Reviews
There are no reviews yet.